Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-10-04 00:00:00 ET · period of report 2022-09-30 · accession 0000899243-22-032862 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-04 | 2022-10-03 | DNA | Dmytruk Mark E. | See Remarks | S - Sale+OE | $3.12 | -7,259 | 9,102 | -44% | -$22.6K |
| D | 2022-10-04 | 2022-09-30 | DNA | Dmytruk Mark E. | See Remarks | M - OptEx | — | +16.4K | 16.4K | New | — |
| D | 2022-10-04 | 2022-09-30 | DNA | Dmytruk Mark E. | See Remarks | M - OptEx | — | -16.4K | 658.1K | -2% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-03 | S | D | 7,259 | $3.12 | 9,102 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-09-30 | M | A | 16,361 | — | 16,361 | D | — | — | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 3 | Derivative | Class B Common Stock | 2022-09-30 | M | D | 16,361 | — | 658,133 | D | — · — to — | — Class A Common Stock | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. (F4) Includes shares of Class B Common Stock that are subject to vesting conditions. |